OI
BLUE

Oakbrook Investments’s bluebird bio BLUE Stock Holding History

Oakbrook Investments’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-100
Closed -$205K – 606
2019
Q1 		$205K Buy
+100
New +$176K 0.01% 582
2018
Q4 		– Sell
-124
Closed -$234K – 580
2018
Q3 		$234K Buy
+124
New +$256K 0.01% 594

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Oakbrook Investments's BLUE Position: Q2 2019 in Review

Oakbrook Investments sold out of bluebird bio (BLUE) in Q2 2019, closing a stake of 100 shares — an estimated $205K sold.

Oakbrook Investments first reported a position in BLUE in Q3 2018 and held it in 2 quarters. The position peaked at $234K in Q3 2018. 273 funds tracked by Wall St. Rank hold BLUE as of Q2 2019.

  • Oakbrook Investments reported no remaining bluebird bio position as of Q2 2019 after selling out during the quarter.
  • Oakbrook Investments sold 100 bluebird bio shares in Q2 2019, an estimated $205K.
  • Oakbrook Investments first reported a position in bluebird bio in Q3 2018 and held it in 2 quarters.
  • Oakbrook Investments's bluebird bio position peaked at $234K in Q3 2018.
  • 273 funds tracked by Wall St. Rank held bluebird bio as of Q2 2019.

Based on Oakbrook Investments's 13F filing for Q2 2019, filed 18 Jul 2019.